Longevity supplements report: Longevity Labs+

Longevity Labs+ – translating scientific findings into natural solutions so people can live longer, healthier lives with spermidineLIFE.

Over the coming weeks, we will be bringing you extracts of 11 company profiles from our Longevity Supplements Report. Each profile includes an assessment of Pre-Clinical and Clinical Studies, Safety and Risks, Target Market and Success Factors and the target Hallmark(s) of Aging for one of their key products.

We also study each company’s IP, team, UVP, product efficacy, competitive advantage, runway and inflection point, and much more. Here’s the lowdown on Longevity Labs+
To view a full size version of Longevity Labs+’s profile please click here.

Longevity Supplements 1.0 Longevity Labs+ Summary

Longevity Labs+, believes in making high quality products inspired by nature and backed by science for increasing human healthspan and lifespan. Founded in 2016, spermidineLIFE® is based on the scientific research of Dr Frank Madeo at the University of Graz.

As its name may suggest, the polyamine spermidine was first isolated from male semen in the 1920s, however, its function was not understood until the 21st century. Dr Madeo was the first scientist to discover the unique ability of spermidine, a polyamine naturally found in every cell of our body, to trigger autophagy and increase human lifespan. It took three years to develop production methods suitable for widescale market distribution in Austria with international expansion commencing in 2020. Longevity Labs+, based in Austria and the US, claims to be the first company to introduce spermidine supplementation into the global market and the only company conducting clinical studies with spermidine through partnerships with leading spermidine and autophagy researchers worldwide.

Herbert Pock, one of three founders, has been a new ventures consultant and advisor for the scientific community for over 25 years. In 2015, while Vedran Bijelac was working under Pock, Pock was asked to evaluate patents, new scientific findings, and research activities at the University of Graz.

This is where he first encountered spermidine. Pock was so struck with the potential of Dr Madeo’s findings that he approached Dr Madeo on potential products from the research. After Dr Madeo expressed a desire to remain focused on scientific research, Pock agreed to oversee the business aspects. With the help of Dr Gerald Sitte overseeing organisational development and Bijelac managing marketing and sales, the three founded Longevity Labs+ and secured Dr Hannes Androsch – a philanthropist, successful serial entrepreneur, and the former Finance Minister of Austria – as the primary investor.

Pock: “As soon as I realized the potential health and human benefits spermidine could have for society, we realised we had to create a company to introduce spermidine into the global market.”

The active ingredient in spermidineLIFE®, the CelVio Complex, is composed of naturally extracted, locally sourced, non-GMO European, wheat germ and has been approved as a novel food in Europe by EFSA. The lab-verified, spermidine-rich full-spectrum extract also includes added polyamines, healthy fats, vitamins, and minerals. This CelVio Complex is the blend used in human clinical trials across the world due to its uniquely high spermidine content and high safety and tolerability.

From the spermidineLIFE® product launch in 2019, sales have increased remarkably, with 40,000 packages sold in 2019 and over 210,000 packages the following year. Interest worldwide continues to grow, and the product is well positioned to be the globally recognised “original” spermidine supplement and ingredient.

Longevity Labs+ uses pharmacies as a third-party distribution channel in Austria, Germany and Italy to make the product easily accessible to the public. First entering the US market in August 2020, spermidineLIFE® is currently sold via the company’s website (spermidinelife.us) and Amazon. Longevity Labs+ plans to eventually team up with pharmacies across the US to expand access and distribution.

Longevity Labs+’s state-of-the-art, in-house manufacturing facility boasts GMP and vegetarian/vegan statuses.

Longevity Labs+ is one of the few supplement companies to conduct its own in-house manufacturing, enabling the company to modify and improve processes and ingredients over time; this is particularly important with natural extract products. The company has grown its maximum production capacity to over 2 million packages per year to accommodate future growth.

After extraction, the company partners with suppliers for capsuling and packaging of the finished product. The products are tested for spermidine concentrations and other quality control markers before being sent off for distribution.

Access to the report and a FREE executive summary can be found here, and check out our other supplements company profiles here.